One-third of older patients undergoing percutaneous coronary interventions (PCI) have diabetes, and those with insulin-dependent diabetes have an increased risk of long-term adverse events after stenting, according to this report from the National Cardiovascular Data Registry. Selecting a drug-eluting stent may reduce the risk of death and myocardial infarction in insuIin-dependent patients, but not in non-insulin-dependent ones. The authors define the risks of additional revascularization and subsequent hospitalization for bleeding in older diabetic patients.
RESULT: Long-Term Outcomes of Older Diabetic Patients After Percutaneous Coronary Stenting in the United States
Journal of the American College of Cardiology | Dec 4, 2012 (FREE FULL TEXT)
One way for diabetes patients to reduce the risks of coronary stenting may be to attain good glycemic control pre-and post-surgery. This study found that glycemic control (HbA1c levels ≤7% before and after PCI) was significantly associated with 1-year outcome, including reduced risks of re-stenosis, in diabetic patients undergoing elective PCI with stent implantation. The authors also discuss the effects of cigarette smoking and waist circumference as predictors for better PCI outcome in these patients.
RESULT: Glycosylated hemoglobin (HbA1c) levels and clinical outcomes in diabetic patients following coronary artery stenting
Cardiovascular Diabetology | Jul 17, 2012 (FREE FULL TEXT)
